Latest News

 Filter by Provider

Anthropic Chief Scientist Dario Amodei has vehemently denied allegations made by Nvidia (NASDAQ: NVDA) CEO Jensen Huang that he is attempting to dominate the AI industry.

A recent poll on Stocktwits found that more than one-third of retail traders expect XRP to post the strongest gains among major cryptocurrencies in August.

Mastercard highlighted a forward-looking strategy centered on open banking, which executives are touting as a key to future growth.

Over the past year, financial headlines have continued to flood investors with doomsday predictions about the U.S. dollar.

Domino’s Pizza Inc. is the largest pizza company in the world based on global retail sales.

USDCNH is advancing above the 200-period moving average MA(200) after returning above MA(200) following a retreat to a 9-month low a week ago.

Arbor Realty Trust (ABR) reported mixed Q2 2025 earnings, with revenue beating estimates but GAAP earnings declining. Stock dipped slightly as investors weigh strong loan growth against lower profitability. Dividend held steady at $0.30 per share.

Regeneron Q2 revenue rose 4% to $3.68 billion, driven by Dupixent and antibody profits, while FDA delays impacted Eylea HD and odronextamab approvals.

W.W. Grainger's Q2 2025 results show mixed performance with revenue slightly beating estimates but EPS and full-year guidance disappointing investors, sparking an 11% pre-market drop.

IRADIMED CORP (IRMD) reported record Q2 2025 earnings, beating estimates with $20.4M revenue and $0.49 EPS. Shares surged 6.27% pre-market as the company raised full-year guidance.

Ocugen Inc (OCGN) reports Q2 2025 earnings with $1.37M revenue, beating estimates by 284%, while EPS loss narrows to -$0.05. Progress in gene therapy trials boosts investor optimism.

Palantir's stock has already doubled this year.

The initial estimate of U.S. median household income in June 2025 is $83,680.

U.S. job growth stalls and unemployment rises in July, raising pressure on the Federal Reserve as Trump reignites attacks on Chair Powell.

President Trump on Thursday announced new tariffs on dozens of countries, marking a resumption of the trade-war policies that he originally outlined in April.

The company raised its full-year platform revenue outlook despite a projected decline in the devices segment.

Colgate-Palmolive topped Q2 estimates and launched a bold 2030 growth plan with up to $300M in restructuring charges.

e.l.f. Beauty has completed its Adhishthana Himalayan formation and now sits in a transitional phase. Here's a breakdown of its structure

The vaccine maker lowered its full-year revenue guidance to a range of $1.5 billion to $2.2 billion, reflecting a $300 million reduction at the high end of the range.

Check out the companies making headlines this week:

The Euro hestitates right above 1.1400 following hotter-than-expected Eurozone inflation figures.

Paylocity (PCTY) is a high-growth stock with strong financials, solid profitability, and a bullish technical breakout pattern, making it a compelling pick for investors.

Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce.